SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001374366-17-000003
Filing Date
2017-02-22
Accepted
2017-02-22 14:08:36
Documents
1
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3671
  Complete submission text file 0001374366-17-000003.txt   5058
Mailing Address C/O REV GROUP, INC. 111 EAST KILBOURN AVENUE, SUITE 2600 MILWAUKEE WI 53202
Business Address
Canan John (Reporting) CIK: 0001374366 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 17627848

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
SIC: 2834 Pharmaceutical Preparations